Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How we approach the use of sirolimus and new agents: Medical therapy to treat vascular anomalies.

Pediatric blood & cancer - 1 Aug 2022

Shimano Kristin A, Eng Whitney, Adams Denise M

Abstract excerpt

Vascular anomalies (VAs) are a heterogeneous group of primarily congenital tumors and malformations. The International Society for the Study of Vascular Anomalies (ISSVA) has developed a standard classification of these disorders, creating a uniform approach to their diagnosis. Recent discoveries evaluating the genetic causes of VAs have revealed that they are due to mutations in cancer pathways, including the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Phosphatidylinositol 3-Kinases
Share to Proto-Oncogene Proteins c-akt

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Sirolimus

Share to Vascular Malformations

Source

Open in PubMed Open full text

Identifiers

PMID: 35253343
DOI: 10.1002/pbc.29603
PMCID: PMC13019703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How we approach the use of sirolimus and new agents: Medical therapy to treat vascular anomalies.PMID 35253343Read ↗

New and Emerging Targeted Therapies for Vascular Malformations.Semantic proximity Read ↗

Targeted medical therapies for vascular anomaliesSemantic proximity Read ↗

Systemic Therapy for Vascular Anomalies and the Emergence of Genotype-Guided Management.Semantic proximity Read ↗

Vascular malformations: An overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapySemantic proximity Read ↗

Targeted treatments for vascular malformations: current state of the art.Semantic proximity Read ↗

Development of Molecular Therapies for Venous Malformations.Semantic proximity Read ↗

Targeted treatment of vascular anomaliesSemantic proximity Read ↗

Genetic Basis and Therapies for Vascular Anomalies.Semantic proximity Read ↗

The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms.Semantic proximity Read ↗

Molecular landscape and classification of vascular anomalies.Semantic proximity Read ↗

Emerging importance of molecular pathogenesis of vascular malformations in clinical practice and classifications.Semantic proximity Read ↗

RAS Pathway Mutations and Therapeutics in Vascular Anomalies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.